Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Titel:
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Auteur:
Rasco, Drew W. Medina, Theresa Corrie, Pippa Pavlick, Anna C. Middleton, Mark R. Lorigan, Paul Hebert, Chris Plummer, Ruth Larkin, James Agarwala, Sanjiv S. Daud, Adil I. Qiu, Jiaheng Bozon, Viviana Kneissl, Michelle Barry, Elly Olszanski, Anthony J.